Breaking Down Shandong Shida Shenghua Chemical Group Company Limited Financial Health: Key Insights for Investors

Curious how Shandong Shida Shenghua Chemical Group (603026.SS) stacks up for investors when the numbers tell a mixed story? The firm posted revenue of ¥5.547 billion in 2024 (down 1.56% year-on-year and off from ¥8.32 billion in 2022) amid a roughly 30% drop in certain average selling prices over two years and roughly ¥150 million in sales from outdated lines (a 10% decline in 2023); profitability is strained with net income of ¥16.42 million in 2024 (net margin ~0.3%), ROE of -2.86%, ROA of -1.05%, gross margin down to 5.2% from 17.44% in 2022 and an operating margin of -0.49%; leverage and coverage show contrasts-reported debt-to-equity of 0.48 and total debt of ¥2.49 billion (debt-to-assets ~48%), yet total liabilities of ¥3.49 billion versus equity of ¥1.66 billion (implying a 2.1 ratio), interest coverage of -2.29 and rising total debt to ¥2.59 billion in 2025 while equity fell to ¥1.62 billion; liquidity flags include a current ratio of 1.28, quick ratio 0.87, operating cash flow of -¥447.6 million and free cash flow of -¥1.07 billion despite a cash balance of ¥1.25 billion (cash per share ¥5.37); market valuation is rich given negative earnings-P/E of -175.5, P/B 1.77, EV/EBITDA 120.17, market cap ¥17.24 billion and EV ¥18.84 billion-and growth vectors show promise with electrolyte capacity expanded to 0.3 million tonnes, shipments >0.06 million tonnes (over threefold y/y), a new 0.2 million-tonne Wuhan project and strengthened ties with major lithium-battery firms-so which of these hard numbers signal risk to avoid versus opportunity to explore?

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Revenue Analysis

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) reported revenue of 5.547 billion yuan in 2024, a 1.56% decrease from 2023. The company's top-line has been on a clear downward trajectory from 8.32 billion yuan in 2022 to 5.55 billion yuan in 2024.

• 2024 revenue: 5.547 billion yuan (-1.56% vs. 2023)
• 2023 revenue: ~5.635 billion yuan (implied)
• 2022 revenue: 8.32 billion yuan
• Average selling price for certain products dropped ~30% over two years
• Revenue per employee: ~2.82 million yuan
• Estimated revenue from outdated product lines (2023): ~150 million yuan (-10% YoY)
• Exposure to declining segments (e.g., pesticides market expected to shrink ~3% by 2024)

Primary drivers behind the decline include a roughly 30% fall in average selling price for select product lines over two years and structural headwinds in segments like pesticides (market size projected to decline ~3% by 2024). Estimated revenue from legacy/outdated product lines was ~150 million yuan in 2023, down about 10% year-over-year, contributing to margin pressure and lower overall top-line.

• Price compression: ~30% average selling price decline for certain products over two years.
• Segment contraction: pesticide market exposure with ~3% shrinkage by 2024.
• Legacy products: ~150 million yuan revenue in 2023 from outdated lines (-10% YoY).
• Productivity: revenue per employee ~2.82 million yuan, reflecting moderate operational productivity.

For broader corporate context and historical details, see: Shandong Shida Shenghua Chemical Group Company Limited: History, Ownership, Mission, How It Works & Makes Money

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Profitability Metrics

• Net income (2024): ¥16.42 million (down 12.32% YoY; 2023 net income ≈ ¥18.73 million)
• Net profit margin (2024): ~0.3%
• Gross profit margin: 5.2% (2024) vs 17.44% (2022)
• Operating margin (2024): -0.49%
• Return on equity (ROE, 2024): -2.86%
• Return on assets (ROA, 2024): -1.05%

• Sharp drop in gross margin from 17.44% (2022) to 5.2% (2024) signals compressing product-level profitability and/or rising input costs.
• Near-zero net margin (~0.3%) despite positive net income indicates limited buffer against volatility.
• Negative ROE and ROA show the company failed to generate positive returns on equity and assets in 2024.
• Operating margin below zero (-0.49%) points to operational inefficiencies or elevated operating expenses relative to revenue.
• For background on the company's structure and business model, see: Shandong Shida Shenghua Chemical Group Company Limited: History, Ownership, Mission, How It Works & Makes Money

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Debt vs. Equity Structure

Key balance-sheet figures and leverage metrics for Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) show a company navigating mixed signals: reported conservative leverage on one metric, but materially higher leverage when measured against total liabilities. Interest coverage is negative, indicating earnings shortfalls relative to interest expense.

• Reported debt-to-equity ratio (company disclosure): 0.48 - suggests a balanced approach to leveraging.
• Total debt (2024): ¥2.49 billion; Total assets: ¥5.15 billion → debt-to-assets ≈ 48%.
• Interest coverage ratio: -2.29 - operating earnings are insufficient to cover interest expense.
• Total liabilities: ¥3.49 billion; Total equity: ¥1.66 billion → implied debt-to-equity (liabilities/equity) = 2.1.
• Total debt rose from ¥2.49 billion in 2024 to ¥2.59 billion in 2025; total equity fell from ¥1.66 billion to ¥1.62 billion over the same period.

• Rising nominal debt alongside shrinking equity increases financial risk and reduces cushion for creditors and shareholders.
• The divergence between the reported debt-to-equity (0.48) and the liabilities/equity calculation (2.1) indicates differences in metric definitions (e.g., net debt vs. gross liabilities) and warrants scrutiny of debt composition (short‑ vs. long‑term, off‑balance items).
• Negative interest coverage signals potential cash-flow pressure; servicing higher debt could require refinancing, asset sales, or equity injections.

Further context on shareholders, trading activity, and investor positioning can be found here: Exploring Shandong Shida Shenghua Chemical Group Company Limited Investor Profile: Who's Buying and Why?

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Liquidity and Solvency

• Current ratio: 1.28 - adequate coverage of current liabilities by current assets.
• Quick ratio: 0.87 - below 1, indicating potential difficulty meeting short-term obligations without relying on inventory sales.
• Cash flow from operations: -447.6 million yuan - negative operating cash flow signaling operational cash pressure.
• Free cash flow: -1.07 billion yuan - substantial negative FCF, consistent with cash burn or heavy investment cycles.
• Cash balance: 1.25 billion yuan - provides a liquidity cushion against operating and investing outflows.
• Cash per share: 5.37 yuan - moderate cash reserve on a per-share basis.

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Valuation Analysis

• P/E ratio: -175.5 - negative earnings, indicating net losses on a per-share basis.
• P/B ratio: 1.77 - market values equity at a 77% premium to book value.
• EV/EBITDA: 120.17 - extremely high multiple versus operating cash-profit proxy.
• P/S ratio: 2.86 - sales are being valued at nearly 3x revenue.
• P/TBV ratio: 3.85 - tangible assets are valued substantially below market capitalization.

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Risk Factors

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) faces a set of material risks that directly affect its short- and medium-term financial health. Below are the primary risk drivers, supported by the latest available figures and market context.

• Intense industry competition: the broader chemical industry recorded an average operating margin of 8.5% in 2022, putting margin pressure on players that cannot scale or differentiate effectively.
• Outdated product lines: legacy products contribute minimally to growth; estimated sales from outdated products were ~150 million yuan in 2023, indicating limited revenue upside and potential margin dilution.
• Exposure to declining segments: the company retains exposure to pesticides and other contracting markets - the pesticide market is forecasted to shrink by ~3% by 2024, reducing addressable demand.
• Profitability concerns: negative interest coverage ratio of -2.29 implies operating earnings are insufficient to meet interest obligations, increasing refinancing and default risk.
• Cash flow strain: operating cash flow is negative 447.6 million yuan, signaling liquidity stress and reliance on external financing or asset sales for working capital.
• Leverage profile: debt-to-equity ratio of 0.48 suggests moderate leverage, which provides some financial flexibility but does not offset earnings and cash-flow weaknesses.

Key triggers and monitoring points for investors:

• Quarterly operating cash flow trends - continued negative cash flow increases short-term liquidity risk.
• Interest expense vs. EBITDA movement - improvement in EBITDA or lower interest costs needed to move interest coverage positive from -2.29.
• Revenue mix shift - reduction in outdated-product contribution (150 million yuan) and reallocation toward higher-margin or growing segments.
• Market exposure - management actions addressing shrinking pesticide demand (projected -3% to 2024).
• Refinancing requirements - given negative cash flow, watch upcoming debt maturities relative to debt-to-equity of 0.48.

For contextual corporate background and business model details see: Shandong Shida Shenghua Chemical Group Company Limited: History, Ownership, Mission, How It Works & Makes Money

Shandong Shida Shenghua Chemical Group Company Limited (603026.SS) - Growth Opportunities

• Electrolyte capacity expanded to 0.30 million tonnes (annualized).
• Annual shipment volume exceeded 0.06 million tonnes, a year‑on‑year increase of more than 3×.
• Now ranked among the top ten electrolyte producers in the industry.
• Wuhan base commissioned a 0.20 million tonne electrolyte project and completed first‑batch deliveries.
• Deepened strategic cooperation with leading domestic lithium‑battery manufacturers to secure offtake and tech collaboration.

• Quality improvement initiatives to raise product grade and reduce defect/return rates.
• R&D and technological innovation for next‑generation electrolyte formulations and production efficiency.
• Operational efficiency and lean management to improve margins as scale increases.
• Service optimization, customer support and logistics to strengthen distributor relationships and repeat business.
• Global distributor ambition guided by integrity, high quality, and service standards.